Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB26FHZET
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,102
Award facts
- Contract value 100% obligated
- $11,101.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,101.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 100 unit vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. will serve as the sole prime contractor with no identified subcontractors on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to support Department of Defense medical supply needs worldwide. The underlying contract, designated SPE2DR, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. The PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables, to support recurring military healthcare facility requirements globally, positioning DMS Pharmaceutical Group as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FHZET?
SPE2DB26FHZET was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FHZET worth?
The government has obligated $11,102 on SPE2DB26FHZET.
Is contract SPE2DB26FHZET an order under another contract?
Yes. SPE2DB26FHZET is a delivery order under SPE2DB24D9155, an indefinite delivery contract.
Was contract SPE2DB26FHZET competed?
The extent of competition for SPE2DB26FHZET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award